Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy. [PDF]
Zhang L +8 more
europepmc +1 more source
Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis. [PDF]
Peng Q +7 more
europepmc +1 more source
Comprehensive Identification of Lipid-Membrane Protein Interactions via Advanced Proteomics and Extended Lipid-Immobilized Bead Technology. [PDF]
Morito M +4 more
europepmc +1 more source
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. [PDF]
Wang J, Xu X, Wang Y, Zhu Y.
europepmc +1 more source
Machine learning for early prediction of secondary cancer after radiotherapy. [PDF]
Sadeghi H, Seif F, Khanmohammadi S.
europepmc +1 more source
Related searches:
Abstract 2404: Role of TPD52L2 in cell migration and triple negative breast cancer progression
Cancer Research, 2022Abstract The Golgi apparatus plays an important role in cell migration and the establishment of epithelial polarity. A dispersed (or fragmented) Golgi ribbon is often seen in stressed cells and in various pathologies, including neurodegeneration or cancer, but whether and how a fragmented Golgi apparatus affect cellular function is ...
Seyedamirabbas Parizadeh +3 more
openaire +1 more source
In the present study, we characterized an evolutionarily conserved non-transmembrane ATP-binding cassette protein: hABCF3. Subcellular immunofluorescence staining demonstrated that hABCF3 localizes preferentially in cytoplasm, unlike its paralog protein hABCF1, which localizes in both cytoplasm and nucleus.
Juan, Zhou +4 more
openaire +2 more sources
CORRELATION BETWEEN TPD52L2 EXPRESSION AND RISKS OF RECURRENCE AND METASTASIS IN PROSTATE CANCER
Acta Medica Mediterranea, 2019<p>Objective: To study the correlation between TPD52L2 expression and risks of recurrence and metastasis in patients with prostate cancer. </p> <p>Methods: A total of 150 prostate cancer patients underwent a TPD52L2 gene test and were divided into two groups according to the test findings: the negative (n=35) and positive groups (
openaire +1 more source

